What Healora does

Healora Labs LLC is a US-based direct-to-consumer skincare company operating as Healora, founded in 2015 and headquartered in Santa Monica. The company develops and sells topical dermatological treatments for fungal and moisture-related skin conditions, with a portfolio of five core SKUs: Healora Intertrigo Relief Cream (flagship skin-fold rash product), Athlete's Foot Relief Cream, Pityriasis Versicolor Clearing Cream, the Complete Dandruff Killer System (a 3-step tonic/shampoo/conditioner protocol), and an oral Skin Probiotic Supplement sold as an add-on.

The product technology centers on a proprietary silica-tapioca dry-down matrix that delivers microencapsulated slow-release actives - including tea tree oil, undecylenic acid, salicylic acid, and urea - while transitioning from cream to a powder-finish protective barrier within 60 seconds. The flagship formulation is positioned as the only OTC product addressing all three root causes of intertrigo (moisture, friction, fungal infection) in a single application, with 15+ years of claimed R&D involvement of dermatologists, mycologists, and cosmetic chemists. Products are manufactured in a US FDA-registered, GMP-compliant facility.

The business model is exclusively direct-to-consumer via the company's Shopify-hosted storefront at healora.com, with no Amazon or third-party retail presence. Revenue is generated through one-time bundle purchases ($29.95-$59.95 for 1-3 tube packs) and a recurring subscription/auto-ship program managed on the Loop platform at $24.95-$44.95 per month, supported by a 90-day money-back guarantee and free shipping above $40. Marketing is digital-first: Facebook/Instagram paid social, Google Analytics and Shopify Audiences retargeting, owned email marketing, and review/testimonial-led on-site content. Scale claims range from 12,000+ verified reviews to 50,000-100,000+ satisfied customers across sources, with 70,000+ reported subscription members. Healora is privately held with no disclosed institutional funding and operates with a 1-10 employee team under founder-CEO Thomas Farmer, co-founder/CMO Julian Henley, and CTO Parshant Jain.

Name

Healora

Legal name

Healora Labs LLC

Website

https://healora.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Healora is a direct-to-consumer dermatology brand selling proprietary topical treatments - headlined by Intertrigo Relief Cream, plus athlete's foot, tinea versicolor, and dandruff systems - exclusively through healora.com via subscription and one-time bundles to US consumers.

Ownership category

akta.pro rank

Product category

Topical Dermatological Skincare

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Wound & Ostomy Skin Care (Barrier Films/Creams, Adhesive Removers, Cleansers) (HLAHALAK)

akta.pro secondary industries

Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH), Treatments & Scalp Care (Serums, Oils, Anti-dandruff, Growth) (CRABABAE)

Keywords

• Topical antifungal creams
• Intertrigo treatment
• Skin fold rash relief
• Dermatological skincare
• Direct-to-consumer skincare

Headquarters

HQ city

Santa Monica

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

1. Product Sales (One-Time Purchase): Single purchase of topical dermatology products at varying bundle sizes. One-month supply tubes sold individually or in bundles of 2-3 units with increasing discounts. Primary revenue stream for new customer acquisition.
2. Subscription / Auto-Ship Program: Recurring monthly delivery of product bundles (1-3 tubes) at discounted subscription rates. Subscription model prevents recurrence of chronic skin conditions and creates predictable recurring revenue. Cancel/skip anytime with no commitment. Locked-in pricing for subscribers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Healora formulates and sells clinically-developed topical dermatological creams that treat fungal and moisture-related skin conditions including intertrigo (skin fold rashes), athlete's foot, pityriasis versicolor, and dandruff. Its flagship Intertrigo Relief Cream uses a proprietary silica-tapioca dry-down matrix combined with microencapsulated slow-release actives to address moisture, friction, and fungal infection in a single application. Products are sold exclusively direct-to-consumer through healora.com via one-time purchase or recurring auto-ship subscription.

Product overview

Healora is a direct-to-consumer skincare company specializing in clinically-formulated topical treatments for fungal and moisture-related skin conditions. The product portfolio centers on five core offerings: Healora Intertrigo Relief Cream for skin fold rashes, Athlete's Foot Relief Cream for tinea pedis, Pityriasis Versicolor Clearing Cream for yeast-related discoloration, and the Complete Dandruff Killer System (a 3-step protocol of tonic, shampoo, and conditioner). The company also offers a Skin Probiotic Supplement as an add-on to support topical treatments internally. Products are sold through subscription auto-delivery programs and one-time purchases exclusively via healora.com, with a 90-day money-back guarantee backing all offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Healora Intertrigo Relief Cream A fast-drying relief cream specifically formulated for skin fold rashes (intertrigo), addressing moisture, friction, and fungal infection in a single application with a cream-to-powder finish within 60 seconds. Intended for adults experiencing under-breast, belly fold, groin, inner thigh, and armpit rashes.
• Athlete's Foot Relief Cream A topical antifungal cream for tinea pedis that eliminates itching, peeling, cracking, burning, and foot odor. Formulated with undecylenic acid, salicylic acid, tea tree oil, urea, and zinc oxide to penetrate fungal biofilm and prevent recurrence.
• Pityriasis Versicolor Clearing Cream A topical cream formulated to treat pityriasis versicolor (tinea versicolor) by rebalancing Malassezia yeast populations and supporting natural melanin production through copper peptides and mandelic acid exfoliation, eliminating discoloration and flaking.
• Complete Dandruff Killer System A three-step scalp treatment system consisting of Glycolic Acid Scalp Tonic, Piroctone Olamine Treatment Shampoo, and Cetrimonium Chloride Protective Conditioner that breaches the follicular reservoir, breaks down fungal biofilm, and restores scalp microbiome balance to prevent dandruff recurrence.
• Healora Skin Probiotic Supplement An oral probiotic supplement designed to support skin health from within, intended as a complementary product used alongside Healora topical treatments.

Quantifiable outcome

• 12,000+ five-star verified customer reviews with 4.9/5 aggregate rating
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Lotrimin: Lotrimin is Bayer's leading OTC antifungal brand covering athlete's foot, ringworm, and jock itch with extensive retail presence, serving as a primary category incumbent that competes with Healora's antifungal portfolio at the shelf.
• Lamisil AT: Lamisil AT is Bayer's mass-market OTC antifungal brand for athlete's foot, ringworm, and jock itch sold through pharmacies and grocery, directly overlapping Healora's athlete's foot antifungal cream as the dominant OTC incumbent.
• CeraVe: CeraVe (L'Oréal) is a dermatologist-developed skincare brand sold through mass retail that competes for the same 'medical-grade skincare' positioning and intertrigo-adjacent skin condition buyers who might otherwise consider Healora's barrier creams.
• Head & Shoulders: Head & Shoulders is P&G's mass-market antidandruff shampoo brand, directly competing with Healora's Complete Dandruff Killer System in the same OTC dandruff category with vastly greater distribution and brand awareness.
• Dr. Scholl's: Dr. Scholl's is an established OTC foot care brand selling antifungal treatments (athlete's foot) and skin-protective products through mass retail and pharmacy, overlapping with Healora's Athlete's Foot Relief Cream via the same antifungal use case at much broader distribution.

Emerging players

• Zeasorb: Zeasorb is a focused OTC antifungal/absorbent powder brand targeting moisture and fungal skin fold and foot issues via retail pharmacy, a niche-condition competitor that overlaps directly with Healora's intertrigo positioning on the antifungal powder function.

Direct peers

• Curology: Curology is a DTC personalized prescription skincare brand built around subscription-based custom formulations for acne and related skin concerns, mirroring Healora's direct-to-consumer, subscription-driven dermatology model targeting online consumers with condition-specific products.
• Proactiv: Proactiv is a long-running DTC dermatology brand built around subscription replenishment for a specific skin condition (acne), offering a close structural parallel to Healora's condition-targeted cream + subscription model.
• Beekman 1802: Beekman 1802 is a digitally native skincare brand selling specialized skin and body care directly through its own storefront with subscription options, comparable as a DTC specialist skincare brand targeting condition- or benefit-driven buyers online.
• Hims & Hers Health: Hims & Hers is a large DTC consumer health brand selling dermatology and personal care products directly via its website with subscription replenishment, closely mirroring Healora's owned-website, subscription-first, direct-to-consumer go-to-market.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healora